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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A332Results: The OA group was signiﬁcantly older, had greater BMI, KL
scores and WOMAC scores compared to the asymptomatic group
(Table).
The OA group had signiﬁcantly less MVPA, bouted MVPA, and steps per
day based on accelerometer data, but self-reported more time spent
doing bouted vigorous and bouted MVPA (Table).
In terms of meeting guidelines, based on accelerometer data, 44.4% of
asymptomatic individuals and 8.5% of those with moderate OA met
physical activity guidelines ( >¼150 bouted MVPA min/week), while
18.5% of asymptomatic individuals and 36% of those with moderate OA
were considered inactive (no bouts of MVPA/week). Using self-reports,
74.1% of asymptomatic individuals and 89.4% of thosewithmoderate OA
met physical activity guidelines, while only 3% of asymptomatic indi-
viduals and 2% of those with moderate OA were considered inactive.
Conclusions: Based on objective accelerometer data, the moderate
knee OA group had similar sedentary (9 hours per day) and light (4
hours per day) PA as asymptomatic individuals. Given that long sed-
entary bouts are particularly detrimental to health outcomes, further
work is needed to determine how this timewas distributed over the day
in both groups. The moderate OA group engaged in less time in MVPA
and accrued fewer steps per day compared to asymptomatic individuals
based on accelerometer data. Interesting, the moderate OA group self-
reported greater levels of MVPA. These ﬁndings suggest PA levels are
substantially overestimated using the IPAQ, particularly in individuals
with moderate knee OA, questioning its value in physical activity
assessment in the OA population. The accelerometer data support
efforts to identify safe and effective interventions to increase MVPA in
those with knee joint pathology to ensure PA beneﬁts are achieved in
the OA population.Mean (SD) group demographics and daily physical activity levels.
Asymptomatic Moderate OA p-value
Age (years) 54.7 (7.8) 62.3 (6.8) <0.001
BMI (kg/m2) 27.6 (4.7) 31.2 (5.8) <0.001
WOMAC e Total 2.1 (5.8) 22.3 (18.5) <0.001
KL Global* 2.0 (2) 3 (2) <0.001
Accelerometer e Sedentary (mins) 573.9 (90.7) 541.1 (102.0) 0.181
Accelerometer e Light (mins) 261.6 (54.7) 278.2 (78.1) 0.103
Accelerometer e MVPA (mins) 39.9 (25.0) 21.7 (15.0) <0.001
Accelerometer e Bouted MVPA (mins) 22.4 (21.2) 7.71 (11.12) <0.001
Accelerometer e Step Counts 8357 (2993) 6518 (2426) <0.001
IPAQ e Bouted MVPA (mins) 99.5 (111.6) 171.5 (186.8) 0.01
BMIe Body Mass Index, WOMAC, KL e Kellgren Lawrence (*Mann-Whitney U Test),
MVPA emoderate-vigorous physical activity, IPAQ e International Physical Activity
Questionnaire.532
MANAGING KNEE OSTEOARTHRITIS IN AN ACADEMIC PRIMARY CARE
PRACTICE: OPPORTUNITIES FOR IMPROVEMENT
L. Keshavjee y, N. Gakhal y,z, L. Mahendira x, R. Propp k, N. Ivers y,z.
yUniv. of Toronto, Toronto, ON, Canada; zWomen's Coll. Hosp., Toronto,
ON, Canada; xRoyal Coll. of Surgeons Ireland, Sch. of Med., Dublin,
Ireland; kYork Univ., Toronto, ON, Canada
Purpose: To determine the current management of knee osteoarthritis
(OA) in Women's College Hospital Family Practice Health Team, a large
urban academic primary care practice in Toronto, Ontario, Canada.
Methods: An algorithm was developed to identify patients with knee
OA in the electronic medical record (EMR). The initial search criteria
identiﬁed 2210 patients. The exclusion criteria included patients 40 and
under and patients with a diagnosis of inﬂammatory arthritis (rheu-
matoid arthritis or lupus). A chart review was then conducted and
patients were excluded if the chart did not indicate a diagnosis of knee
osteoarthritis. A diagnosis of knee OA was conﬁrmed by x-ray or family
practice/specialist clinical assessment. This resulted in a ﬁnal cohort of
814 patients with a conﬁrmed diagnosis of knee OA. Patient charac-
teristics and management of the knee OA were then extracted.
Results: 814 (8%) family practice patients over the age of 40 had knee
OA. Of those with conﬁrmed knee OA, 183 (22.4%) were male and 631
(77.5%) were female. Themean age of patients was 65. BMIwas reportedin 513 (63%) patients. The mean BMI was 29.6. 450 (55.3%) patients had
OA indicated in their current problem list and 561 (68.9%) patients had a
knee x-ray completed. 436 (53.6%) patients were being managed in
family practice and had not been referred to sports medicine, ortho-
pedics or rheumatology. 495 (60.8%) patients received counselling on
lifestyle interventions for their knee OA which included weight loss
and/or physiotherapy. 397 (48.8%) patients were recommended to try
acetaminophen and/or an oral anti- inﬂammatory, 45 (5.5%) opioids, 76
(9.3%) steroid injections and 100 (12.3%) topical medication.
Conclusions: Knee OA is a prevalent medical problem in family prac-
tice. Counselling on lifestyle interventions for knee OA is not optimized
given the evidence of its effectiveness and the prevalence of obesity in
the population. These results formed the basis of a quality improvement
project to optimize the management of knee OA in primary care that is
currently being piloted.
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INTRAARTICULAR INJECTION OF HYALURONIC ACID IN KNEE AND
PHYSICAL THERAPY AGENTS FOR THE TREATMENT OF KASHIN
BECK DISEASE: A PROSPECTIVE INTERVENTIONAL STUDY
W. Wang y, P. Yuan z, X. Guo x. y The Second Afﬁliated Hosp., Xian Jiaotong
Uinversity, Xian, China; z Shaanxi Traditional Chinese Med. Coll., Xianyang,
China; xKey Lab. of Environment and Genes Related to Diseases, Hlth.Sci.
Ctr., Xian Jiaotong Uinversity, Xian, China
Purpose: To determine whether hyaluronic acid (HA) or Physical ther-
apy agents (PTA) can improve functional parameters in patients with
knee Kashin-Beck Disease (KBD).
Methods: In a 2-year, 55 patients were treated with HA weekly for 5
weeks, then 6th and 7th injections on the3ird month and 6th month for
a total of seven injections.53 patients were treated with PTA ﬁve times a
week for 3 weeks every month for 6 months. The patients were eval-
uatedwith theWestern Ontario andMcMaster University Osteoarthritis
Index (WOMAC) and the visual analog pain scale.
Results: During the study, after the treatment interruption, pain
increased rapidly in the PTA group (from amean value of 85.7 ±83.8mm
at month 12 to 145.2 ±128.8mm at month 18 and 201.3 ±150.5mm at
month 24 )while it remained stable in the HA group (from amean value
of 80.7 ±70.6 mm at month 12 to 90.1±95.2mm at month 18 and 82.6
±85.3mm at month 24) with a statistically signiﬁcant difference in
favour of HA at month 18(P < 0.05) and month 24(P < 0.05). Joint
stiffness, physical functionand total WOMAC showed the same trend as
pain. The global efﬁcacy judgments by the patients and the inves-
tigators are presented a statistically signiﬁcant difference in favour of
HA at month 18(P< 0.05) and month 24(P<0.05).
Conclusions: Although all patients had improvement for both pain and
function, HA was superior to PTA alone for pain relief and remained
longer.
